Having a parent with depression was associated with structural differences in the brains of 9- and 10-year-olds, according to a study published online in the Journal of the American Academy of Child & Adolescent Psychiatry.
The US Food and Drug Administration (FDA) recently granted Usona Institute, Madison, Wisconsin, the Breakthrough Therapy designation for psilocybin in the treatment of patients with major depressive disorder (MDD).
At both lower and higher doses, a yoga and breathing intervention improved symptoms of depression and anxiety in a group of people with major depressive disorder (MDD), according to a study published recently in the Journal of Psychiatric Practice.
Resting-state electroencephalographic (EEG) data may help in predicting the outcome of escitalopram treatment in patients with major depressive disorder (MDD), suggests a study published online in JAMA Network Open.
Knowing someone with emotional or mental health problems increased the likelihood that people who screened positive for depression sought out depression treatment for themselves, according to a study published online in Psychiatric Services.
SAN DIEGO—Mental health clinicians aren't talking to their patients enough about sexual dysfunction commonly associated with depression and its treatment, Anita Clayton. MD, stated at Psych Congress 2019.
SAN DIEGO—Added to standard-of-care treatment, esketamine nasal spray rapidly reduced depressive symptoms in patients at imminent risk of suicide, according to two phase 3 trials presented at Psych Congress 2019.
Exercise is effective for both preventing and treating depression, yet the intervention does not receive the acknowledgement it warrants in clinical practice, reports a new review and meta-analysis published in Current Sports Medicine Reports.